Preoperative plasma levels of transforming growth factor ?1 strongly predict clinical outcome in patients with bladder carcinoma
Open Access
- 13 December 2001
- Vol. 92 (12) , 2985-2992
- https://doi.org/10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyJournal of Clinical Oncology, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostateCancer, 1993
- Current Management of Invasive and Metastatic Transitional Cell Carcinoma of the BladderJournal of Urology, 1993
- Magnetic Resonance Imaging in the Staging of Bladder CancerPublished by Wiley ,1993
- The Rationale for EN Bloc Pelvic Lymph Node Dissection for Bladder Cancer Patients with Nodal Metastases: Long-Term ResultsJournal of Urology, 1993
- Results of Contemporary Radical Cystectomy for Invasive Bladder Cancer: A Clinicopathological Study With an Emphasis on the Inadequacy of the Tumor, Nodes and Metastases ClassificationJournal of Urology, 1991
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Computerized Tomography: An Unreliable Method for Accurate Staging of Bladder Tumors in Patients who are Candidates for Radical CystectomyJournal of Urology, 1989
- Reliability of CT in Preoperative Evaluation of Bladder CarcinomaScandinavian Journal of Urology and Nephrology, 1988